Phase II Study of Soy Protein to Treat Vasomotor Symptoms in Postmenopausal Women Taking Tamoxifen
RATIONALE: Soy protein supplement may be effective in reducing hot flushes in postmenopausal women who are receiving tamoxifen for breast disease.
PURPOSE: Randomized phase II trial to determine the effectiveness of soy protein supplement in reducing hot flushes in postmenopausal women who are receiving tamoxifen for breast disease such as ductal hyperplasia or breast cancer.
100 Clinical Results associated with Protein Technologies International, Inc.
0 Patents (Medical) associated with Protein Technologies International, Inc.
100 Deals associated with Protein Technologies International, Inc.
100 Translational Medicine associated with Protein Technologies International, Inc.